Beijing Peking University WBL Biotech Co., Ltd. (WPU) is a high-tech pharmaceutical joint-venture of Peking University, the Asiapharm Group Ltd of Singapore and the Beijing Enterprises Holdings Limited of Hong Kong, which was founded in 1994 with registered capital of RMB80 million. Our company mainly engages in the research, development, production and marketing of natural drugs and modern Chinese medicines.



Xuezhikang capsule (XZK), the lipid-regulating Chinese medicine, is a leading product of WPU. It is an extract from Red Yeast Rice (Hong Qu) and is highly effective in...